Literature DB >> 21120636

Phenotypic heterogeneity in a SOD1 G93D Italian ALS family: an example of human model to study a complex disease.

Silvana Penco1, Christian Lunetta, Lorena Mosca, Eleonora Maestri, Francesca Avemaria, Claudia Tarlarini, Maria Cristina Patrosso, Alessandro Marocchi, Massimo Corbo.   

Abstract

We report different clinical expression in seven members of a large family with amyotrophic lateral sclerosis (ALS) and the G93D mutation in exon 4 of the Cu/Zn superoxide dismutase (SOD1) gene. The ALS clinical course in the proband showed an unusually fast progression of the disease compared to the paucisymptomatic presentation associated to this mutation in the two previously Italian families described. The remaining mutation carriers did not show the aggressive clinical course displayed by the proband. We selected few genes known to be ALS modifiers searching for genetic variants that could explain the wide phenotypic diversity within the family. Exclusion of causative genes such as TDP43, FUS, PGRN and VAPB was performed too. We believe that this kind of family with contrasting phenotypes of ALS may be considered an excellent human model to study the relationship between a wider genetic profile, including modifier genes, and the clinical expression of the disease. Therefore, the novelty of our approach is also represented by the study of a single family to reproduce a composite structure in which search for possible modifier genes/genetic variants linked to SOD1 mutated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21120636     DOI: 10.1007/s12031-010-9480-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  36 in total

1.  The rare G93D mutation causes a slowly progressing lower motor neuron disease.

Authors:  Gabriella Restagno; Federica Lombardo; Luca Sbaiz; Cristina Mari; Cinzia Gellera; Dario Alimonti; Andrea Calvo; Luisella Tarenzi; Adriano Chiò
Journal:  Amyotroph Lateral Scler       Date:  2008

2.  Lack of association of PON polymorphisms with sporadic ALS in an Italian population.

Authors:  Claudia Ricci; Stefania Battistini; Lorena Cozzi; Michele Benigni; Paola Origone; Lorenzo Verriello; Christian Lunetta; Cristina Cereda; Pamela Milani; Giuseppe Greco; Maria Cristina Patrosso; Renzo Causarano; Claudia Caponnetto; Fabio Giannini; Massimo Corbo; Silvana Penco
Journal:  Neurobiol Aging       Date:  2010-04-09       Impact factor: 4.673

3.  Paraoxonase gene mutations in amyotrophic lateral sclerosis.

Authors:  Nicola Ticozzi; Ashley Lyn LeClerc; Pamela J Keagle; Jonathan D Glass; Anne-Marie Wills; Marka van Blitterswijk; Daryl A Bosco; Ildefonso Rodriguez-Leyva; Cinzia Gellera; Antonia Ratti; Franco Taroni; Diane McKenna-Yasek; Peter C Sapp; Vincenzo Silani; Clement E Furlong; Robert H Brown; John E Landers
Journal:  Ann Neurol       Date:  2010-07       Impact factor: 10.422

4.  A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology.

Authors:  J B Leverenz; C E Yu; T J Montine; E Steinbart; L M Bekris; C Zabetian; L K Kwong; V M-Y Lee; G D Schellenberg; T D Bird
Journal:  Brain       Date:  2007-04-17       Impact factor: 13.501

5.  Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase.

Authors:  P M Andersen; P Nilsson; V Ala-Hurula; M L Keränen; I Tarvainen; T Haltia; L Nilsson; M Binzer; L Forsgren; S L Marklund
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

6.  Hypoxic conditions stimulate the production of angiogenin and vascular endothelial growth factor by human renal proximal tubular epithelial cells in culture.

Authors:  Masayuki Nakamura; Hideaki Yamabe; Hiroshi Osawa; Norio Nakamura; Michiko Shimada; Ryuichiro Kumasaka; Reiichi Murakami; Takeshi Fujita; Tomohiro Osanai; Ken Okumura
Journal:  Nephrol Dial Transplant       Date:  2006-02-20       Impact factor: 5.992

Review 7.  The genetics of motor neuron diseases.

Authors:  Denise A Figlewicz; Richard W Orrell
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2003-12

Review 8.  Genetics of familial amyotrophic lateral sclerosis.

Authors:  Paul N Valdmanis; Guy A Rouleau
Journal:  Neurology       Date:  2008-01-08       Impact factor: 9.910

9.  A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS.

Authors:  A-M Wills; S Cronin; A Slowik; D Kasperaviciute; M A Van Es; J M Morahan; P N Valdmanis; V Meininger; J Melki; C E Shaw; G A Rouleau; E M C Fisher; P J Shaw; K E Morrison; R Pamphlett; L H Van den Berg; D A Figlewicz; P M Andersen; A Al-Chalabi; O Hardiman; S Purcell; J E Landers; R H Brown
Journal:  Neurology       Date:  2009-03-25       Impact factor: 9.910

10.  Mutation of SOD1 in ALS: a gain of a loss of function.

Authors:  Daniela Sau; Silvia De Biasi; Laura Vitellaro-Zuccarello; Patrizia Riso; Serena Guarnieri; Marisa Porrini; Silvia Simeoni; Valeria Crippa; Elisa Onesto; Isabella Palazzolo; Paola Rusmini; Elena Bolzoni; Caterina Bendotti; Angelo Poletti
Journal:  Hum Mol Genet       Date:  2007-05-15       Impact factor: 6.150

View more
  6 in total

Review 1.  The phenotypic variability of amyotrophic lateral sclerosis.

Authors:  Bart Swinnen; Wim Robberecht
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

2.  Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice.

Authors:  Maria Chiara Trolese; Carlotta Scarpa; Valentina Melfi; Paola Fabbrizio; Francesca Sironi; Martina Rossi; Caterina Bendotti; Giovanni Nardo
Journal:  Mol Ther       Date:  2022-04-27       Impact factor: 12.910

3.  EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans.

Authors:  Annelies Van Hoecke; Lies Schoonaert; Robin Lemmens; Mieke Timmers; Kim A Staats; Angela S Laird; Elke Peeters; Thomas Philips; An Goris; Bénédicte Dubois; Peter M Andersen; Ammar Al-Chalabi; Vincent Thijs; Ann M Turnley; Paul W van Vught; Jan H Veldink; Orla Hardiman; Ludo Van Den Bosch; Paloma Gonzalez-Perez; Philip Van Damme; Robert H Brown; Leonard H van den Berg; Wim Robberecht
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

4.  The tyrosine kinase receptor Tyro3 enhances lifespan and neuropeptide Y (Npy) neuron survival in the mouse anorexia (anx) mutation.

Authors:  Dennis Y Kim; Joanna Yu; Ryan K Mui; Rieko Niibori; Hamza Bin Taufique; Rukhsana Aslam; John W Semple; Sabine P Cordes
Journal:  Dis Model Mech       Date:  2017-01-12       Impact factor: 5.758

5.  Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis.

Authors:  Melissa M Haulcomb; Rena M Meadows; Whitney M Miller; Kathryn P McMillan; MeKenzie J Hilsmeyer; Xuefu Wang; Wesley T Beaulieu; Stephanie L Dickinson; Todd J Brown; Virginia M Sanders; Kathryn J Jones
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

Review 6.  Gene Therapy in Amyotrophic Lateral Sclerosis.

Authors:  Ton Fang; Goun Je; Peter Pacut; Kiandokht Keyhanian; Jeff Gao; Mehdi Ghasemi
Journal:  Cells       Date:  2022-06-29       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.